Timeline

2015

1ªs Certificações

Primeiras certificações GMP e GDP suíça e
europeia, para os extratos de Cannabis,
incluindo o CBD.

2016

Validação de Métodos e Processos

2017

CPhI

Apresentação do óleo CBD Isolado, durante
o maior evento farmacêutico mundial, a CPhI,
em Frankfurt, Alemanha.

2017

Pipeline do TCH

Autorização da SWISSMedic para
desenvolvimento de extratos à base de
Cannabis, ricos em THC.

2019
cbd

Promediol® CBD

Promediol® CBD é lançado
na Europa e na Suíça.

2020
cbd

Promediol® CBD FULL Spectrum

Promediol® CBD FULL Spectrum é lançado

na Suíça e no Brasil.

Promediol™

Swiss Therapeutic Solutions

It is proven that, not all Cannabis products available in the market have the concentration stated at their labels. Therefore, the dosage becomes imprecise, which impacts directly in the patient’s treatment and expected results. In order to supply this deficit, Promediol™ Swiss Therapeutic Solutions, was created to be a range of therapeutic solutions using Cannabis extracts, with pharma grade and swiss quality.
We comply with all relevant pharmaceutical standards and European Good Practices guidelines.

Our products are certified by Swissmedic (Swiss Agency for Therapeutic Products) and
recognized by E.M.A. (European Medicines Agency)

Good Manufacturing Practices

Good Agricultural Practices

Good Distribution Practices

Worldwide shipment

✓ International delivery
✓ Tracking service
✓ Advanced logistic
✓ Climatized temperature
✓ Electronic monitoring

Totally monitored, from order to delivery.